{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:08:02Z","timestamp":1720609682689},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1157\/13094277","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T13:55:13Z","timestamp":1163685313000},"page":"36-45","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["Los aspectos epidemiol\u00f3gicos cambiantes de la candidemia y sus implicaciones clinicoterap\u00e9uticas"],"prefix":"10.1016","volume":"24","author":[{"given":"Miguel","family":"Salavert Llet\u00ed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Jarque Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pem\u00e1n Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13094277_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/514955","article-title":"The impact of candidemia on length of hospital stay, outcome, and overall cost of illness","volume":"27","author":"Rentz","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib3","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib4","first-page":"30","article-title":"Descripci\u00f3n de 165 episodios de funguemia de un estudio multic\u00e9ntrico","volume":"16","author":"Sota","year":"1999","journal-title":"Rev Iberoam Micol"},{"key":"10.1157\/13094277_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib6","first-page":"51","article-title":"Infecci\u00f3n sist\u00e9mica nosocomial por levaduras","volume":"18","author":"Cant\u00f3n","year":"2001","journal-title":"Rev Iberoam Micol"},{"key":"10.1157\/13094277_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","article-title":"Risk factors for candidemia in neonatal intensive care unit patients","volume":"19","author":"Saiman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13094277_bib8","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1157\/13094277_bib9","first-page":"441","article-title":"Sanz MA. Delay of onset of candidemia and emergence of Candida krusei fungemia in haematological patients receiving prophylactic fluconazole","volume":"85","author":"Jarque","year":"2000","journal-title":"Haematologica"},{"key":"10.1157\/13094277_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1157\/13094277_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/jcrc.2002.35815","article-title":"Systemic candidiasis in intensive care units: a multicenter, matched-cohort study","volume":"17","author":"Leleu","year":"2002","journal-title":"J Crit Care"},{"key":"10.1157\/13094277_bib13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Le\u00f3n","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1157\/13094277_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/376993","article-title":"The epidemiology of burn wound infections: then and now","volume":"37","author":"Mayhall","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1067\/mpd.2002.122499","article-title":"A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States","volume":"140","author":"Grohskopf","year":"2002","journal-title":"J Pediatr"},{"key":"10.1157\/13094277_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1099\/0022-1317-51-2-110","article-title":"Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia","volume":"51","author":"Krcmery","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1157\/13094277_bib17","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole prophylaxis against fungal colonization and infection in preterm infants","volume":"345","author":"Kaufman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13094277_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","article-title":"The epidemiology of hematogenous candidiasis caused by different Candida species","volume":"24","author":"Abi-Said","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhin.2001.1151","article-title":"Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance","volume":"50","author":"Krcmery","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1157\/13094277_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1086\/517694","article-title":"Fluconazole and the changing epidemiology of candidemia","volume":"27","author":"Girmenia","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib22","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Eng J Med"},{"key":"10.1157\/13094277_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10096-004-1267-5","article-title":"Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain","volume":"24","author":"Pem\u00e1n","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib24","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients","volume":"37","author":"Wingard","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13094277_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/jhin.2001.1131","article-title":"Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use","volume":"50","author":"Hope","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1157\/13094277_bib26","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1001\/archinte.160.17.2659","article-title":"Candida krusei fungemia. An escalating serious infection in immunocompromised patients","volume":"160","author":"Abbas","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1157\/13094277_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib28","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility","volume":"43","author":"Arendrup","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13094277_bib29","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13094277_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s10096-002-0713-5","article-title":"Two cases of fungemia due to Candida lusitaniae and a literature review","volume":"21","author":"Viudes","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkh532","article-title":"Candida krusei fungaemia: antifungal susceptibility and clinical presentation o fan uncommon entity during 15 years in a single general hospital","volume":"55","author":"Mu\u00f1oz","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13094277_bib32","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/320757","article-title":"Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia","volume":"32","author":"Uzum","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10096-002-0697-1","article-title":"Risk factors for breakthrough candidemia","volume":"21","author":"Nucci","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib34","first-page":"535","article-title":"Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes","volume":"87","author":"Pagano","year":"2002","journal-title":"Haematologica"},{"key":"10.1157\/13094277_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s100960000335","article-title":"Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for management","volume":"19","author":"Clancy","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/338714","article-title":"Should vascular catheters be removed from all patients with candidemia? An evidence-based review","volume":"34","author":"Nucci","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1157\/13056690","article-title":"Recomendaciones para el diagn\u00f3stico micol\u00f3gico y estudios de sensibilidad a los antif\u00fangicos","volume":"22","author":"Gadea","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13094277_bib38","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/JCM.35.12.3284-3287.1997","article-title":"Detection of antibodies to Candida albicans germ tubes for diagnosis and therapeutic monitoring of invasive candidiasis in patients with hematologic malignancies","volume":"35","author":"Garc\u00eda-Ruiz","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13094277_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0213-005X(04)73039-6","article-title":"Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis","volume":"22","author":"Moragues","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13094277_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1086\/380643","article-title":"Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases","volume":"38","author":"Martino","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib41","unstructured":"Pel\u00e1ez T, Garc\u00eda-Arias V, Alcal\u00e1 L, Fern\u00e1ndez-Chico A, Bl\u00e1zquez A, Guinea JV, et al. Epidemiology and in vitro antifungal susceptibilities of Trichosporon spp.: an overview of a 15-year period. 43rd ICAAC, September 2003, p. 468. Abstract M-1222."},{"key":"10.1157\/13094277_bib42","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/429916","article-title":"Saccharomyces cerevisiae fungemia: an emerging infectious disease","volume":"40","author":"Mu\u00f1oz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1157\/13052334","article-title":"Recomendaciones para el tratamiento de la infecci\u00f3n f\u00fangica invasiva. Infecci\u00f3n f\u00fangica invasiva por Candida spp","volume":"21","author":"Gavald\u00e1","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13094277_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10096-002-0730-4","article-title":"Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators","volume":"21","author":"B\u00fcchner","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib46","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0213-005X(06)73772-7","article-title":"Tratamiento de las infecciones f\u00fangicas invasoras","volume":"24","author":"Pach\u00f3n","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13094277_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0732-8893(03)00086-5","article-title":"Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001)","volume":"46","author":"Marco","year":"2003","journal-title":"Diag Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib48","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1157\/13094277_bib49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10096-003-1014-3","article-title":"Voriconazole salvage treatment of invasive candidiasis","volume":"22","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10096-002-0854-6","article-title":"Duration of antifungal treatment and development of delayed complications in patients with candidaemia","volume":"22","author":"Oude Lashof","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13094277_bib51","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1157\/13094277_bib52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jac\/dkh548","article-title":"In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003","volume":"55","author":"Cuenca-Estrella","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13094277_bib53","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13094277_bib54","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13094277_bib55","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"2","author":"Pacho","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X06738988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X06738988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:53:25Z","timestamp":1587257605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X06738988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":55,"alternative-id":["S0213005X06738988"],"URL":"https:\/\/doi.org\/10.1157\/13094277","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}